Background: The versatility and immense potential of nanoparticles and nanostructures
have made them crucial building blocks for a wide range of applications. Achieving precise …

Effective delivery of therapeutic and diagnostic nanoparticles is dependent on their ability to
accumulate in diseased tissues. However, most nanoparticles end up in liver macrophages …

The objective of this manuscript is to provide quantitative insights into the tissue distribution
of nanoparticles. Published pharmacokinetics of nanoparticles in plasma, tumor and 13 …

Increasing evidences show that unmodified extracellular vesicles (EVs) derived from various
cells can effectively inhibit the malignant progression of different types of tumors by …

Therapies targeting neurological conditions such as Alzheimer's or Parkinson's diseases are
hampered by the presence of the blood-brain barrier (BBB). During the last decades, several …

The use of nanoparticles for developing vaccines has become a routine process for
researchers and pharmaceutical companies. Gold nanoparticles (GNPs) are chemical inert …

Nanomaterials have revolutionized medicine by enabling control over drugs'
pharmacokinetics, biodistribution, and biocompatibility. However, most nanotherapeutic …

The ability of upconversion nanoparticles (UCNPs) to convert low-energy near-infrared
(NIR) light into high-energy visible-ultraviolet light has resulted in their development as …

Nanoparticles (NPs) hold great potential as therapeutics, particularly in the realm of drug
delivery. They are effective at functional cargo delivery and offer a great degree of …

Subconjunctival administration of nanocarriers presents an alternative drug delivery strategy
to overcome blood-ocular barriers to enhance drug bioavailability to specific parts of the eye …